Literature DB >> 27407312

PROBLEMS IN MANAGEMENT OF KALA AZAR: EXPERIENCE FROM BIHAR.

S P Rai1, S Bandyopadhyay2.   

Abstract

35 cases of Kala-Azar were managed at 200 bedded peripheral hospital, Bihar from Jan 1994 to Jan 1998. Patients presenting with history of fever for more than 3 weeks duration with splenomegaly or hepatosplenomegaly were investigated for Kala-Azar. A confirmative diagnosis of Kala-Azar was made in all cases by demonstrating Leishmania amastigote (LD body) in bone marrow or splenic aspirate. All patients were initially treated by sodium stibogluconate (SSG) 20 mg/kg body wt daily for 20 to 40 days depending on response. SSG induced cardiac toxicity was seen in 6 cases (VT-2, ST-T changes-2, QTc Prolongation-2) out of which 1 patient died of refractory ventricular tachyacarida. 9 patients were unresponsive to SSG,8 patients were treated with pentamidine isoethionate (4 mg/kg body wt IV alternate day) 10-15 dosage. 1 patient was treated with amphotericin-B. All the patients showed clinical and parasitological improvement and no relapse was noted at 6 month follow up. 6 patients had associated tuberculosis (Disseminated TB-2, Miliary TB-1, Pulmonary TB-1. Pleural TB-2). 2 patients had associated pneumonia, 1 patient had HIV infection and 1 patient had erythema nodosum leperosum.

Entities:  

Keywords:  Kala-Azar; Pentamidine isoethionate; Sodium Stibogluconate

Year:  2011        PMID: 27407312      PMCID: PMC4925848          DOI: 10.1016/S0377-1237(01)80128-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  8 in total

1.  Prolonged sodium stibogluconate therapy in Indian kala-azar.

Authors:  T K Jha; V K Sharma
Journal:  J Assoc Physicians India       Date:  1986-07

2.  Kala-azar mortality in hospitalized cases in north Bihar, India.

Authors:  N K Singh; D Sharma; T K Jha
Journal:  J Assoc Physicians India       Date:  1989-08

3.  Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.

Authors:  C P Thakur; M Kumar; P Kumar; B N Mishra; A K Pandey
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

4.  Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil.

Authors:  J M Blackwell
Journal:  Int J Parasitol       Date:  1998-01       Impact factor: 3.981

5.  Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis.

Authors:  S Sundar; F Rosenkaimer; M L Lesser; H W Murray
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

6.  Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial.

Authors:  S N Jha; N K Singh; T K Jha
Journal:  J Assoc Physicians India       Date:  1991-04

7.  Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study.

Authors:  C P Thakur; M Kumar; A K Pandey
Journal:  Am J Trop Med Hyg       Date:  1991-10       Impact factor: 2.345

Review 8.  Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.

Authors:  B L Herwaldt; J D Berman
Journal:  Am J Trop Med Hyg       Date:  1992-03       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.